LNTH

Lantheus Holdings (LNTH)

About Lantheus Holdings (LNTH)

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Details

Daily high
$108.28
Daily low
$105.05
Price at open
$108.28
52 Week High
$126.89
52 Week Low
$50.20
Market cap
7.6B
Dividend yield
0.00%
Volume
54,324
Avg. volume
633,640
P/E ratio
17.89

Lantheus Holdings News

Details

Daily high
$108.28
Daily low
$105.05
Price at open
$108.28
52 Week High
$126.89
52 Week Low
$50.20
Market cap
7.6B
Dividend yield
0.00%
Volume
54,324
Avg. volume
633,640
P/E ratio
17.89